| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 07/22/2004 | WO2004060316A2 Irs modulators |
| 07/22/2004 | WO2004060310A2 Human growth hormone crystals and methods for preparing them |
| 07/22/2004 | WO2004060307A2 Synthetic neutropoiesis-stimulating proteins |
| 07/22/2004 | WO2004060304A2 Novel compositions and methods in cancer |
| 07/22/2004 | WO2004060302A2 Methods and compositions for the diagnosis, prognosis, and treatment of cancer |
| 07/22/2004 | WO2004060300A2 Polymer conjugates of cytokines, chemokines, growth factors, polypeptide hormones and antagonists thereof with preserved receptor-binding activity |
| 07/22/2004 | WO2004060282A2 Uses of the snorf207 receptor |
| 07/22/2004 | WO2004060280A2 Methods and compositions for inhibiting the growth of hematopoietic malignant cells |
| 07/22/2004 | WO2004060275A2 Wound care compositions |
| 07/22/2004 | WO2004060270A2 Compositions and methods for the diagnosis and treatment of tumor |
| 07/22/2004 | WO2004060269A2 Mda-7 and free radicals in the treatment of cancer |
| 07/22/2004 | WO2004060262A2 Modulators of notch signalling for use in immunotherpapy |
| 07/22/2004 | WO2004060055A1 Wt1 transgenic animal |
| 07/22/2004 | WO2004060053A2 Transgenic mice expressing human cd20 |
| 07/22/2004 | WO2004060052A2 Transgenic mice expressing human cd20 and/or cd16 |
| 07/22/2004 | WO2004060041A2 Kim-1 antagonists and use to modulate immune system |
| 07/22/2004 | WO2004050696A3 Antimicrobial polypeptide isolated from rhizomucor pusillus |
| 07/22/2004 | WO2004046178A3 Shrew paralytic peptide for use in neuromuscular therapy |
| 07/22/2004 | WO2004044168A8 Genetically encoded fluorescent reporters of kinase, methyltransferase, and acetyl-transferase activities |
| 07/22/2004 | WO2004044000A3 Compounds and methods for modulating functions of classical cadherins |
| 07/22/2004 | WO2004041843A3 Hop - a novel cardiac-restricted transcriptional factor potentially useful for cardiac regeneration and specification |
| 07/22/2004 | WO2004039978A3 Human chondroosteomodulin (tig2), production, and use for the treatment or diagnosis of bone diseases, cartilage diseases, obesity, inflammatory diseases, and skin diseases |
| 07/22/2004 | WO2004035789A9 Gene families associated with cancers |
| 07/22/2004 | WO2004035086A3 Method for treatment of demyelinating central nervous system disease using gm-csf |
| 07/22/2004 | WO2004033717A9 Autism gene |
| 07/22/2004 | WO2004033498A3 .pharmaceutical composition comprising ht4d100a receptors, and therapeutic uses thereof |
| 07/22/2004 | WO2004031367A3 Uses of human zven proteins and polynucleotides |
| 07/22/2004 | WO2004029081A3 Modified glp-1 peptides with increased biological potency |
| 07/22/2004 | WO2004026331A8 Peptides inhibiting specific cleaving activities of presenilins |
| 07/22/2004 | WO2004024884A3 Syts as modifiers of the p21 pathway and methods of use |
| 07/22/2004 | WO2004022759A3 Method for improving corn starch extractability |
| 07/22/2004 | WO2004021977A3 Nucleic acid and corresponding protein entitled 98p4b6 useful in treatment and detection of cancer |
| 07/22/2004 | WO2004019974A3 Immunogenic composition comprising an il-13 element and t cell epitopes, and its therapeutic use |
| 07/22/2004 | WO2004014936A3 Mixture of peptides from c and ns3 proteins of the hepatitis c virus and applications thereof |
| 07/22/2004 | WO2004014418A3 Neisserial vaccine compositions comprising a combination of antigens |
| 07/22/2004 | WO2004014417A3 Vaccine compositions comprising l2 and/or l3 immunotype lipooligosaccharides from lgtb- neisseria minigitidis |
| 07/22/2004 | WO2004013279A9 Helix-hairpin-helix motifs to manipulate properties of dna processing enzymes |
| 07/22/2004 | WO2004009822A3 Use of specific myb genes for the production of transgenic plants tolerant to biotic and abiotic stresses |
| 07/22/2004 | WO2004007661A3 Carboxy protection strategies for acidic c-terminal amino acids in chemical ligation of oligopeptides |
| 07/22/2004 | WO2004007547A3 Truncated tau proteins |
| 07/22/2004 | WO2004006843A3 Combination therapies with l-fmau for the treatment of hepatitis b virus infection |
| 07/22/2004 | WO2004005529A3 GEF-H1b: BIOMARKERS, COMPLEXES, ASSAYS AND THERAPEUTIC USES THEREOF |
| 07/22/2004 | WO2003092587A3 Modulation of bacterial membrane permeability |
| 07/22/2004 | WO2003089452B1 Compositions and methods for regulation of plant gamma-tocopherol methyltransferase |
| 07/22/2004 | WO2003085084A3 Hepatitis c virus sub-genomic replicons |
| 07/22/2004 | WO2003077863A3 Method for overexpression of zwitterionic polysaccharides |
| 07/22/2004 | WO2003075849A3 Composition and method for enhancing immune response |
| 07/22/2004 | WO2003075843A3 Multiple and multivalent dna vaccines in ovo |
| 07/22/2004 | WO2003074560A3 Critical hypoxia-inducible factor-1alpha residues, products and methods related thereto |
| 07/22/2004 | WO2003072710A3 Protein biomarkers that distinguish prostate cancer from non-malignant cells |
| 07/22/2004 | WO2003059949A3 A protein that mediates angiogenesis and tumour growth inhibition, its cdna, alone or in complex with an expression vector |
| 07/22/2004 | WO2003052078A3 Insect g protein-coupled receptor genes and uses thereof |
| 07/22/2004 | WO2003044174A3 Mammary-associated serum amyloid a3 promoter sequences and uses for same |
| 07/22/2004 | WO2003039477A3 Generation of virus-like particles and demonstration of lipid rafts as sites of filovirus entry and budding |
| 07/22/2004 | WO2003039470A3 Polyvalent immunogen of hiv |
| 07/22/2004 | WO2003031583A3 Generation of virus-like particles by vsv |
| 07/22/2004 | WO2003027253A3 Variants of alpha-fetoprotein coding and expression sequences |
| 07/22/2004 | WO2003024302A3 Detection and treatment of cancers of breast |
| 07/22/2004 | WO2003022869A3 Human immunodeficiency virus envelope clycoprotein mutants and uses thereof |
| 07/22/2004 | WO2003012395A3 Early detection of mycobacterial disease using peptides |
| 07/22/2004 | WO2003004623A3 Human secreted proteins |
| 07/22/2004 | WO2003002718A3 Identification and characterization of multiple splice variants of the mu opioid receptor gene |
| 07/22/2004 | WO2003000735A3 Nucleic acids encoding olfactory receptors |
| 07/22/2004 | WO2002102992A8 Novel nucleic acids, polypeptides, methods of making, and uses thereof |
| 07/22/2004 | WO2002074239A3 Compositions and methods for the treatment and clinical remission of psoriasis |
| 07/22/2004 | WO2002059281A3 High level cytokine production with enhanced cell viability |
| 07/22/2004 | US20040143872 Genetic control of organ abscission |
| 07/22/2004 | US20040143870 Comprises nucleotide sequences coding polypeptide associated with branch migration during genetic exchanged for use as for use as gene transfer enhancement tool during genetic engineering |
| 07/22/2004 | US20040143865 Transgenic fish models for identifying inhibitors of neovascularization; antitumor/antiproliferative agents; wound healing agents |
| 07/22/2004 | US20040143864 Chimeric gene constructs for generation of fluorescent transgenic ornamental fish |
| 07/22/2004 | US20040143863 Expression vectors comprising bone morphogenic protein for use in the transformation of osteoblast and controlling propagation and enrichment of stem cells in vivo |
| 07/22/2004 | US20040143860 Novel presenilin associated membrane protein (PAMP)and uses thereof |
| 07/22/2004 | US20040143859 Novel proteins and methods for producing the proteins |
| 07/22/2004 | US20040143858 Protein associated with phagocytic cells for use as tools in characterizing immune response |
| 07/22/2004 | US20040143857 Erythropoietin analog-human serum albumin fusion |
| 07/22/2004 | US20040143856 Comprises nucleotide sequences coding tumor associated antigen for tredating and preventing autoimmune and cell proliferative disorders; antiproliferative agents |
| 07/22/2004 | US20040143113 Comprises nucleotide sequences coding integrin for identifying modulators which can be utilized to treat and diagnosis cancer; cosmetic; nutraceuticals |
| 07/22/2004 | US20040143111 Comprises human apoptosis-associated protein (HAAP) for treating and preventing cell proliferation or inflammatory disorders |
| 07/22/2004 | US20040143110 Comprises nucleotide sequences for use as diagnostic tools in identifying allelic sequences associated with blood sugar defects |
| 07/22/2004 | US20040143105 Purified heat shock protein complexes |
| 07/22/2004 | US20040143104 Methods of treating diabetes and other blood sugar disorders |
| 07/22/2004 | US20040143103 Comprises nucleotide sequences coding mitogens for treating psoriasis, vision defects, tumors and arthritis |
| 07/22/2004 | US20040143102 Ligand polypeptide for identifying modulators for treatment of nervous system disorders, schizophrenia and arthritis |
| 07/22/2004 | US20040143101 Immunoglobulin construct containing anti-mucin variable domain sequences for eliciting an anti-idiotype anti-tumor response |
| 07/22/2004 | US20040143098 Comprises nucleotide sequences coding polypeptides for use in the transformation and generation of drought, heat, freeze and disease resistant plants |
| 07/22/2004 | US20040143097 Expression vectors coding interleukin polypeptide for use in prevention and treatment of infections, autoimmune, and cell proliferative disease and for stimulating the proliferation of platelets; wound healing agents |
| 07/22/2004 | US20040143096 Interferon for use in the treatment of infections, autoimmune, nervous system and viral diseases and for restoring normal blood cell levels in patients suffering from anemia or receiving chemotherapy for cancer |
| 07/22/2004 | US20040143095 for treating high body temperature, appetite dysfunction, congestive heart failure, vascular disease, stress and anxiety; angiogenesis inhibitors; genetic engineering |
| 07/22/2004 | US20040143093 Method for inducing a conformational transition in proteins, such as pathogenic/infectious proteins, and their use |
| 07/22/2004 | US20040143092 Regulation of human dorsal root receptor-like g protein-coupled receptor |
| 07/22/2004 | US20040142901 Production of pancreatic islet cells and delivery of insulin |
| 07/22/2004 | US20040142894 HiNF-P (Histone Nuclear Factor P) enhances H4 histone gene transcription, activates the cell cycle phase transition of G1 to S, resulting in cell proliferation; expression vector containing HiNF-P polypeptide; transgenic mouse |
| 07/22/2004 | US20040142891 Genes involved in immune related responses observed with asthma |
| 07/22/2004 | US20040142889 fusion polypeptide, comprising a first part which is capable of binding to an antigen bearing target and a second part which is capable of binding to a cell |
| 07/22/2004 | US20040142888 Modulators of RabGGT and methods of use thereof |
| 07/22/2004 | US20040142885 host cell; gene therapy |
| 07/22/2004 | US20040142884 Compositions and methods for the acceleration of protein secretion dynamics |
| 07/22/2004 | US20040142872 Polyamine modified antibodies having specific binding affinity for A beta also have increased permeability at the blood-brain barrier and can be used for passive immunization and treatment of Altzheimer's disease |
| 07/22/2004 | US20040142871 Osteoporosis treatment |
| 07/22/2004 | US20040142870 N-terminally monopegylated human growth hormone conjugates, process for their preparation, and methods of use thereof |